Ciprofloxacin ophthalmic recalls

The FDA has published 3 recalls involving Ciprofloxacin ophthalmic since 2016. The latest was reported on 25 Jan 2023. Most were for manufacturing (cgmp) deviations. Actavis Pharma has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2016
Last 12 months0reported
Class I00% of total
Ongoing1latest 25 Jan 2023

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 2 67%Class III 1 33%

Why ciprofloxacin ophthalmic is recalled

By year

Ongoing ciprofloxacin ophthalmic recalls

1 active

All ciprofloxacin ophthalmic recalls, newest first

3 total

Should you stop taking Ciprofloxacin ophthalmic?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.